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ABSTRACT 
The monitoring of personnel for exposure to radioactive elements is a regulatory 
requirement for any nuclear installation and due to the nature of the research, the need 
for a non-invasive procedure for the monitoring for exposure to plutonium has been 
identified at the South African Nuclear Energy Corporation (NECSA). Historically, 
analyses of short-lived radioactive elements were performed by α-spectrometry. But 
due to the well documented drawbacks of the older generation of α-spectrometer 
analysis, Quadrupole Inductively Coupled Mass Spectrometry (Q-ICP-MS) was 
suggested as an alternative technique. 
A feasibility study was undertaken to determine whether sub-trace concentrations of 
plutonium in urine can be determined using a modern, standard Q-ICP-MS. A 
simplified One Variable at a Time (OVAT) approach was used to establish optimal 
analytical conditions starting from instrument setup and ending in sample 
preparation.  
The optimum sample preparation determined required 50 mL urine which underwent 
co-precipitation, wet-ashing and solid phase extraction using Tetra Valent Actinide 
(TEVA)-resin. Calibration standards ranged from 5 to 100 pg L-1 and the optimised 
method produced LOD’s of 0.2 pg L-1 and LOQ’s of 0.5 pg L-1.  Sample intra-assay 
precision at 0.5- and 15 pg L-1 were 11.3% and 4.43% respectively, in the urine 
matrix. The bias was 8% and 0% at the same concentrations. The method was 
evaluated using samples from an international proficiency study and two out of the 
three tests that could be quantified passed specification. According to ISO 13528 a 
method is acceptable if two out of three tests pass. 
The method has been verified and a modern, standard Q-ICP-MS has been proven to 
be a suitable alternative to α-spectrometry with respect to sub-trace plutonium 
analysis. 
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CHAPTER ONE– Introduction 
1.1 Background 
When uranium is placed in a nuclear reactor, a fraction of the 238U absorbs a neutron 
and is converted to 239U. 239U undergoes β-decay to form 239Np which also undergoes 
β-decay to form 239Pu (http://nuclearweaponarchive.org/Library/Plutonium/ 
Accessed: 05/01/2016). The reaction chain can be summarised as follows: 
ܷଽଶଶଷ଼ +  ݊଴ଵ =  ܷଽଶଶଷଽ ఉିௗ௘௖௔௬ሱۛ ۛۛ ۛۛ ሮ ܰଽଷଶଷଽ ݌ ఉିௗ௘௖௔௬ሱۛ ۛۛ ۛۛ ሮ ܲଽସଶଷଽ ݑ 
Scientists at the Nuclear Energy Corporation of South Africa (NECSA) are 
developing a process to recover uranium from 99Mo process waste residue (Stassen, 
2015) which contains trace amounts of plutonium. Personnel on this project have to 
be monitored for exposure to plutonium. It is important for accurate bioassay of 
plutonium because it is a radioactive element that undergoes spontaneous fission and 
is a strong alpha emitter (Voelz, 2000). Because of this, external exposure to radiation 
is not a big concern as even a sheet of paper (or 3-5 cm of normal atmosphere) is 
enough to absorb the emitted He-particle.  
Plutonium analyses are normally performed by α-spectrometry, which is still the 
preferred method in use at NECSA. Two major drawbacks of this method are:  
 the cost of the analysis due to tedious sample preparation 
 the time it takes to produce a reliable result due to longer counting times for 
low-activity radionuclide's (Ting et al.,2003; Bouvier-Capley et al.,2004).  
Counting times can be anything from 1 day to a week per sample (Bouvier-Capley et 
al., 2004). Having similar sensitivity and higher sample throughput, techniques such 
as Thermal Ionisation Mass spectrometry (TIMS), Resonance Ionisation Mass 
Spectrometry (RIMS) and Accelerator Mass Spectrometry (AMS) are reliable as 
alternatives to α-spectrometry (Pappas et al., 2004) but these instruments are not 
readily available.  During the last few decades, ICP-MS has started to dominate the 
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market for the analysis of long-life radio-nuclides (Hernandez-Mendoza et al., 2011). 
Limits of detection for different analytical techniques are shown in Figure 1.1. 
 
 
ICP-MS has the advantage of lower LOD’s, and decreased analysis times (Ting et al., 
2003; Bouvier-Capley et al., 2004). The main concerns for ICP-MS are the spectral- 
and non-spectral interferences from the heavy urine matrix and the presence of 
uranium which could interfere with the analysis of plutonium by the following 
means: 
 peak tailing from the 238U + isotope if its relative concentration is significantly 
higher than that of plutonium  
 the polyatomic interference from uranium hydride, 238UH+ (Pappas et al., 
2004).   
In most references, one or more sample preparation steps are used to reduce or 
eliminate possible interferences. Sample preparation of urine requires separation from 
the matrix by alkaline co-precipitation of the actinides using Ca3(PO4)2 (EICHROM 
Technologies, 2000; Wyse et al., 1994; Kuwabara et al., 2002) and/or separation of 
Pu by using TEVA columns (EICHROM Technologies, 2000; Pappas et al., 2004), 
Figure 1.1 : LOD's for different analytical techniques (Boulyga, 2011) 
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TRU-resin (Wyse et al., 1994; Kuwabara et al., 2002; Epov et al., 2005), Dowex 1X2 
and 1X8 Anion Exchange resin (Hernandez-Mendoza et al., 2011) or Chelex-resin. 
In this study, a Q-ICP-MS was systematically optimised starting from sensitivity to 
increase the CPS/ppb, and ending with precision to reduce the method imprecision. 
Once the instrument was considered optimal, the focus moved to sample preparation. 
Systematic evaluation and optimisation for sample preparation started with different 
sample preparation procedures, and ended with additional tests to evaluate the 
robustness of the process. During sample preparation evaluation, it was established 
that solid-phase extraction is unavoidable when the lowest possible Limit of 
Detection (LOD) and Limit of Quantification (LOQ) is required. This required 
additional evaluation to ensure that during the solid-phase extraction, as much as 
possible sample matrix (U included) is removed prior to recovering the adsorbed Pu. 
   
1.2 Research Question 
The research was based on addressing one main question. That is: 
Can a standard, modern Q-ICP-MS analyse Pu at concentrations as low as 0.2 pg L-1 
as required by the NECSA SHEQ department and similarly to the current α-
spectrometric technique? 
 
1.3 Research Hypothesis 
The research was based on the hypothesis that: 
Ho: A standard, modern Q-ICP-MS cannot analyse Pu concentrations equal to or 
lower than 0.2 pg L-1. 
Ha:  A standard, modern Q-ICP-MS can analyse Pu concentrations equal to or lower 
than 0.2 pg L-1. 
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1.4 Research Aim & Objectives 
i) The aim of the study is to determine whether a standard, unmodified Q-ICP-MS 
can analyse Pu concentrations similar to or lower than that of α-spectrometry. 
The Aim was achieved by addressing the following objectives: 
 To determine optimal settings for highest instrument sensitivity. 
 To determine optimal sample preparation by balancing the method 
concentration factor and analysis practicality. 
 To establish accuracy and precision over the analytical working range to 
determine method LOD/LOQ. 
 To verify the method using samples from an international proficiency scheme 
spiked with Pu. 
1.5 Significance of Research 
There are two aspects to the significance of the research: 
1) To determine whether a standard Q-ICP-MS using modern technology can achieve 
similar LOD's compared to that of modified systems or specialized instruments. 
2) To determine whether a drastic reduction in the typical sample volume to be 
processed will still allow quantification of Pu at the same LOD and other figures 
of merit as α-spectrometry. This will result in quicker turnaround time, less 
sample load on the laboratory and more convenient handling of samples. 
 
1.6 Structure of Dissertation 
In chapter 1 the general background was given with respect to how plutonium is 
formed inside a nuclear reactor, the health risk associated with possible exposure, the 
drawbacks with the current analytical capability of NECSA, a quick glance at 
historical developments and how the feasibility study was conducted. The Literature 
5  
Review is presented in chapter 2 where the references and the stated analytical 
performances were scrutinized and compared to each other as to give an indication of 
what can be expected from this study. The Research Methodology is presented in 
chapter 3 and covers the theoretical framework, design of experiment, materials and 
reagents. Data gathered as well as deductions made from them will be presented in 
Chapter 4. The conclusion and final recommendations will be presented in the final 
chapter, Chapter 5. 
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CHAPTER TWO –Literature Review 
 
2.1 Radiological hazard of plutonium  
It is when plutonium is either inhaled, ingested or absorbed through a wound where it 
enters the bloodstream and up to 80% of the retained plutonium is deposited in the 
lungs, liver or bone (Voelz, 2000). That is why lung, liver and bone cancers are the 
main concern from plutonium exposure (Burns, 2002). It is important to emphasis the 
retained plutonium because the radiological hazard depends on how the plutonium 
enters the body as well as the particle size. Ingested plutonium passes through the 
gastrointestinal tract with as little as 0.05% and 0.001% retained for soluble- and 
insoluble compounds respectively (Burns, 2002). Only 2% of the retained plutonium 
leaves the body through the urinary tract. The rest is excreted via faeces.  
Inhalation of plutonium particles holds the largest risk. The particle size dictates how 
easily it is absorbed unto the lungs. Particles that are larger than 10 µm pose minimal 
risk as they are swallowed and pass through the gastrointestinal tract. Between 1- and 
10 µm of the particles are retained a little longer, but are also removed through the 
throat via cilia(hair like structures) (Burns, 2002). Particles smaller than 1 µm are 
transported by even the smallest of pathways, where they make their way to the lungs 
and deposit on the alveoli. These particles have the longest retention coefficients 
(Voelz, 2000).  
Every time a plutonium molecule decays, an α-particle is emitted. And for every α-
particle, a path of ion pairs is left in its wake as illustrated by Figure 2.1. If enough 
cells are damaged, tissues may be affected and organs may be impaired. 
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Figure 2.1: The movement of an ejected α-particle through cells (Voelz, 2000) 
 
 
2.2 Instrumentation 
2.2.1 Introduction 
Q-ICP-MS is a hyphenated technique which uses a high temperature Ar-plasma for 
an ion source (which was already in use with ICP-OES), and a quadrupole (used in 
GC-MS) as a mass filter (Skoog et al, 2007).  Since its introduction in the early 
1980’s, ICP-MS has rapidly developed and started to dominate the analytical market 
as it can deliver minimal detection limits, has isotopic capability and has the highest 
throughput (Thomas, 2004).  
 
2.2.2 Principles of analysis 
The sample (typically as a liquid) is transported into the nebulizer where the liquid is 
converted into a fine mist. The mist is carried by Ar-gas into the Ar-plasma where 
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elements undergo several processes until they are ionised. The cations (as part of the 
ion beam) are bent and focused by the lens before entering the quadrupole.  In the 
quadrupole the ions are separated based on their m/z ratio where m is the atomic mass 
and z is the charge (usually +1) (Agilent,2005). The detector measures the signal 
strength of each ion and generates a mass spectrum. The whole process from sample 
uptake to signal generation is summarised by Figure 2.2. 
 
 
Figure 2.2: Schematic of the processes that lead to signal generation in ICP-MS (Agilent,2005) 
 
2.2.3 Q-ICP-MS components 
The instrument used for this study is the Agilent 7700X Q-ICP-MS. Most of the 
components can be seen in Figure 2.3. 
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Figure 2.3: Agilent 7700X  
2.2.3.1 Peristaltic pumps 
The peristaltic pumps (A) consist of 10 rollers which place pressure on flexible 
tubing with the help of a spring-loaded cam. This allows continuous and pulse-free 
flow of sample solution (Figure 2.4) to be carried from the sample container to the 
Sample Loop(C) by the peristaltic pump, and from the Sample Loop to the nebulizer 
by the Nebulizer pump (Skoog et al, 2007). 
 
Figure 2.4: The mechanism of a peristaltic pump (Skoog et al, 2007) 
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2.2.3.2 Nebulizer 
Inside the concentric quartz nebulizer (E) (Refer to Figure 2.7), the liquid sample is 
carried through the inner quartz tube while argon flows at approx. 1 L/min through 
the outer quartz tube. As the sample flows out of the tip, the high velocity Ar gas 
converts (nebulizes) the liquid into a fine mist. This mist is then carried into the spray 
chamber (Agilent Technologies Inc., 2009). 
 
2.2.3.3 Spray chamber 
The sample mist droplet sizes vary when the mist is formed in the nebulizer. The 
spray chamber (E) acts primarily as a droplet size filter where small droplets are 
transported by the carrier gas into the plasma and large droplets collide with the 
chamber wall (Figure 2.5) and are drained by one of the 3 channels of the peristaltic 
pump (Agilent Technologies Inc.,2009). The secondary function of the spray chamber 
is to reduce any pulses that could have been created by the peristaltic pumps 
(Thomas, 2004) 
 
 
Figure 2.5: Nebulizer and Spray Chamber (Agilent Technologies Inc., 2009) 
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2.2.3.4 Torch 
The sample mist is transported from the spray-chamber to the torch (F) which 
contains three concentric quartz tubes (Figure 2.6). In the inner tube, the sample 
aerosol is carried into the plasma with argon carrier gas (approx. 1 L min-1). In the 
middle tube, argon auxiliary gas flows. The outer tube is where argon coolant gas 
flows, also called the Plasma gas (at ca 14 L min-1). This serves to stabilize and 
thermally isolate the plasma (Thomas, 2004).  
 
 
Figure 2.6: ICP Torch and Plasma (Agilent Technologies Inc,2009) 
 
2.2.3.5 Plasma  
The plasma normally has an intense white core and a flame like tail, and consists 
mainly of argon ions and electrons in equilibrium with each other (Skoog et al, 2007). 
The Ar-plasma allows most elements of interest to be ionized with efficiencies larger 
than 90% (Agilent Technologies Inc., 2009). The temperature ranges of a plasma are 
illustrated in figure 2.7. 
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Figure 2.7: The plasma and typical temperature ranges (Skoog et al, 2007) 
 
2.2.3.6 Interface 
After the ions have formed in the plasma, they travel a short distance to the interface 
(G) which is kept under vacuum to ensure the integrity of the ion beam. The ion beam 
first passes through the sampling cone (orifice approx. 1.0 mm) where it expands. A 
fraction of the expanded beam is sampled by the skimmer cone (orifice approx. 
0.4mm). The skimmer acts as a differential aperture between the interface and 
intermediate vacuum stages of the instrument. The interface vacuum is sustained by a 
rotary valve vacuum pump, while the intermediate vacuum is sustained by a turbo 
molecular pump (Agilent Technologies Inc.,2009). 
 
2.2.3.7 Ion Lenses 
The ion beam contains not only analyte ions but also neutral species and photons 
(Thomas, 2004). The aforementioned two have to be removed in order to get better 
sensitivity and lower background for more reliable results. For improved beam 
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bending and focusing, the Agilent 7700x has a 5-piece ion-lens separated by ceramic 
spacers because each has a different voltage applied to it. The Omega Bias-x lens 
serves to bend the beam of ions and thus eliminate all the neutral particles (photons 
are removed at the detector) (Agilent Technologies Inc., 2009). Figure 2.8 shows the 
different components of the Agilent 7700 lens. 
 
 
Figure 2.8: Exploded view of the 7700 ion-lens optics (Agilent Technologies Inc., 2009) 
 
2.2.3.8 Collision/reaction cell (ORS) 
After the ion beam exits the optic lenses, it enters the collision/reaction cell (ORS). 
When activated in analysis mode, the cell has a constant stream of gas flowing 
through it. Helium or hydrogen is commonly used although other gases such as 
ammonia, oxygen and methane are also used in certain cases.  The cell can be used in 
one of two ways. a) where interfering polyatomic species can be reduced by collision 
with the gas and b) where analyte/interfering isobaric-, polyatomic species are 
converted to non-interfering species by reaction with the gas (Thomas, 2004). The 
collision/reaction cell slightly reduces sensitivity and was not activated for this study. 
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2.2.3.9 Quadrupole  
After the ions exit the ORS, they enter the quadrupole mass filter(H) which consists 
of four cylindrical rods placed parallel to each other. Opposite pairs are connected 
electronically to a DC current with polarity alternating at radio frequency(RF) 
between one set(positive) and the other(negative). As Figure 2.9 illustrates, the rods 
act as a mass filter when the DC and RF current are varied, allowing only a specific 
m/z ratio to have a stable trajectory through the rods (Agilent Technologies Inc., 
2009). 
 
Figure 2.9: The quadrupole filtering a single m/z ratio (Thomas ,2004) 
 
Lower DC and RF voltages are selected for lighter m/z ratios and higher voltages for 
larger m/z ratios. The resolution of a quadrupole is expressed as: 
ܴ =  ௙మ௅మ௏                       (2.1) 
     
f is the frequency, L is the quadrupole length and V is the velocity of the ion (Agilent 
Technologies Inc., 2009). The disadvantages are that the quadrupole cannot 
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distinguish isobaric - and polyatomic interferences from ions of the analyte with the 
same m/z ratio. 
 
2.2.3.10 Electron Multiplier (Detector) 
The electron multiplier (I) consists of multiple dynodes. The ion hits and ejects 
electrons from the initial dynode, which are attracted to the next dynode where more 
electrons are ejected.  At the end, a large amount of electrons is generated for each 
ion that hits the initial dynode (Agilent Technologies Inc., 2009). The detector is 
usually placed off axis to the quadrupole so as to reduce the background noise arising 
from photons and other stray radiation (Thomas, 2004).  The 7700 detector consists 
of two modes. Pulse mode for low concentrations which uses all the dynodes for 
electron multiplication, and analog mode for high concentrations where approx. half 
the dynodes are used for multiplication. The two modes are not linear and a P/A-
factor has to be measured in order to establish linearity over 10 orders of magnitude 
(Agilent Technologies Inc., 2009). 
 
2.3 Limit of detection 
The LOD of an analytical method is important because it gives some information 
about parameters such as accuracy, precision and sensitivity. These parameters are 
determined by both instrumental technique and sample preparation. It is therefore 
important to investigate what LOD’s had been previously reported in the literature 
and how the LOD's were improved over time. From the literature there are four main 
factors that affect the LOD of an analytical method namely: the type of instrument 
used, modifications to the instrument (to further boost sensitivity), sample volume 
treated and sample purification. 
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2.3.1 Type of instrumentation 
Work performed by Epov et al. (2005) shows the difference in the capabilities of a Q-
ICP-MS and a sector field inductively coupled plasma mass spectroscopy (SF-ICP-
MS). LOD’s were determined by each of these instruments using the conventional 
pneumatic nebulizer. The Q-ICP-MS’s LOD was determined to be 230 pg L-1 while 
the Double Focusing SF-ICP-MS (DF-SF-ICP-MS) reached a LOD of 5 pg L-1. The 
DF-SF-ICP-MS is superior because it has higher sensitivity (1x106 CPS/ppb) and 
lower background with the help of ion-transfer optics, a magnetic field mass filter and 
electrostatic analyser. Hernandez-Mendoza et al., (2011) also compared LOD’s from 
three different techniques.  The α-spectrometry method produced an LOD of 0.05     
pg L-1, SF-ICP-MS was 0.01 pg L-1 and AMS was 0.005 pg L-1. This partly 
contradicts the publication by Boulyga (2011) which indicates that AMS cannot 
report LOD’s as low as those for ICP-MS. One of the early publications on the 
analysis of plutonium in urine by Wyse and Fischer (1994) employed a matrix 
purification step using TRU-resin and reported a LOD of 100 pg L-1. For comparison 
more recent LOD's have been established as 0.19pg L-1 (Epov et al, 2005). A similar 
volume of sample was processed, but slightly different sample preparation was 
employed. Samples were microwave digested before matrix purification by TRU-
resin. The main factor determining improvement in the LOQ was the technology. In 
10 years the LOD has been reduced from 100 pg L-1 to 0.19 ng L-1, approx. 500 times 
lower. The instrumentation used by Epov et al. (2005) was a SF-ICP-MS coupled 
with a desolvating sample introduction system. The Pelindaba Analytical 
Laboratories (PAL) currently only have a standard Q-ICP-MS, and it would be 
beneficial to determine how a modern Q-ICP-MS method with no modifications 
compares to these published methods. 
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2.3.2 Instrument modification 
With the exception of Hang et al. (2004), all of the references relating to plutonium 
analysis in urine used modified systems to increase sensitivity and by extension, 
lower the LOD’s. These include systems with an extra primary pump to increase 
vacuum (Baglan et al., 2000), replacing the pneumatic nebulizer with an ultra-sonic 
nebulizer (Wyse and Fisher, 1994; Kuwabara et al., 2001), or replacing the standard 
sample introduction with a desolvating introduction system (Ting et al., 2003; Zoriy 
et al., 2005; Pappas et al., 2004). Epov et al. (2005) also illustrated the effect of 
adding a desolvating introduction system to both Q-ICP-MS (Figure 2.10) and DF-
SF-ICP-MS (Figure 2.11) compared to standard systems. This results in an average 
LOD reduction of approximately 5x which agrees with comments by Wyse and 
Fisher, (1994). 
 
Figure 2.10: Comparison of LOD by addition of desolvating introduction system for Q-ICP-MS 
 
Figure 2.11: Comparison of LOD by addition of desolvating introduction system for DF-SF-ICP-MS 
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2.3.3 Sample volume 
There is a correlation between the volume of sample processed and the LOD. Only a 
few publications described sample treatment on sample volumes less than 50 mL with 
higher LOD's than those obtained with larger volumes. For example, Pappas et al. 
(2004) reported a LOD of 0.19 pg L-1 by treating 1 mL of sample compared to 0.01 
pg L-1 from Hernandez-Mendoza et al. (2011) who treated 370 mL for the same 
instrument.  Ting, et al. (2003) reported a LOD of 4.7 pg L-1 by processing a sample 
of 10 g (≈10 mL assuming density = 1 g mL-1) compared to Kuwabara et al., (2001) 
who reported 0.13 pg L-1 by treating 1000 mL urine. The higher the sample volume 
prepared, the lower the concentration of plutonium that can be detected.  For this 
reason, most publications use sample volumes greater than 500 mL (Kuwabara et al., 
2001; Baglan et al., 2000; Zoriy et al., 2005; Sherrod et al., 2008). For the scope of 
this study, 50 mL was selected as the sample volume as it is sufficient volume for a 
10x concentration factor, yet sufficient for a spot-sample. PAL does not have the 
capacity or equipment to process 1 L samples.   
 
2.3.4 Sample purification 
ICP-MS analysis suffers both spectroscopic and non-spectroscopic interferences 
(Hernandez-Mendoza et al., 2011), especially in a heavy urine matrix. Spectroscopic 
interferences occur where atomic-or molecular ions formed in the plasma, have the 
same atomic mass (or more specifically m/z ratio) as the element of interest. This will 
interfere with the analysis by causing an increase on the measured m/z ratio which 
will result in false concentration determinations (Evans and Guglio, 1993). For 
actinides in urine, the spectroscopic interferences resulting from uranium have been 
thoroughly investigated and if plutonium is expected in the urine, the uranium will 
also be present in greater concentrations. Uranium form the 238UH+ ion which is 
isobaric to 239Pu (Wyse et al., 1994; Baglan et al., 2000; Ting et al., 2003; Zoriy et al., 
2005; Epov et al., 2005; Maxwell et al., 2011). Pappas et al. (2004) also reported that 
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samples containing organic matter also causes a polyatomic interference on the 
m/z=239 signal. Non-spectroscopic interferences can either enhance or reduce the 
analyte signal by affecting properties such as sample transport, ionisation, or ion 
throughput (Evans and Guglio, 1993). An example of non-spectroscopic interference 
is the suppression of signal when analysing undiluted urine or with a small dilution 
factor (Wyse et al., 1994; Hang et al., 2004; Pappas et al., 2004; Zoriy et al., 2005). 
Because of a combination of very low concentrations of plutonium and the 
interferences from the urine matrix, emphasis has to be placed on sample preparation 
as this is what determines whether the method will be successful or not. Ting et al. 
(2003) reported, as illustrated by Figure 2.12, there is a trade-off between the time 
spent on removing the matrix, and the LOD that can be achieved. 
 
Figure 2.12: LOD dependence on sample preparation for different radionuclide's. (Bouvier-Capley et al., 2004) 
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They reported an LOD of 230 pg L-1 for a dilution as compared to 4.7 pg L-1 for a 
microwave acid digested sample when using a SF-ICP-MS. Kuwabara et al., (2001) 
reported an LOD of 0.13 pg L-1 using a less sensitive Q-ICP-MS, but spent 
considerably more time on sample preparation. Samples were co-precipitated, 
microwave oven digested, solid-phase separated and microwave acid digested again 
prior to analysis. 
 
2.4 TEVA-resin for actinide analysis 
For this application where the plutonium is the only analyte of interest, TEVA is the 
more suited resin as opposed to Uranium and Tetra Valent Actinides (UTEVA)-resin 
or Trans Uranium elements (TRU)-resin (as per email correspondence with Steffen 
Happle: Eichrom method specialist). The Tetra-Valent Actinides selective resin is the 
quaternary ammonium salt (Aliquat 336) with the structure:                             
(C8H17/ C10H21)3-N+-CH3.  
Figure 2.13 shows how the TEVA columns can aid the separation of uranium and 
plutonium with a suitable rinse solution. 
 
Figure 2.13: Dependence of retention factor (k') for different acid concentrations 
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The most basic steps required to perform actinide separation on a TEVA column were 
attained from EICHROM Technologies (2001), and EICHROM analytical procedure 
ACU02. A co-precipitation step is used to remove the plutonium from the liquid 
phase. The heavy urine matrix can then be discarded as the supernatant. The samples 
are then placed on a hotplate with HNO3 and H2O2 to remove any remaining organic 
matter. A valence adjustment step is performed to convert all the plutonium to the 
tetravalent species, which has the highest retention factor on TEAV-resin, before 
being passed through the TEVA-packed column. The loading solution should be 
more acidic (>1M HNO3) to retain the plutonium. A suitable solution is passed 
through the column to strip the plutonium from the resin and then analysed via Q-
ICP-MS. 
 
2.5 Current actinide analysis trends 
Every year, NECSA participates in an international actinide proficiency scheme in 
which labs are requested to submit information about the method used. The following 
data (figure 2.14 – figure 2.17) was obtained from the 2016 Procorad results where at 
least 65 laboratories participated to show current practices and trends. Figure 2.14 
shows that wet assay is still the predominant sample treatment, used by 70% of the 
participating laboratories.  
 
Figure 2.14: The preferred sample mineralization for actinide analysis in 2016 
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Figure 2.15 shows the preferred co-precipitation step. The (Ca)3(PO4)2 should have 
been included in the total for Alkaline earth precipitation. This study will utilize the 
predominant co-precipitation step, used by ≈ 64% of the laboratories. 
 
Figure 2.15: The preferred sample co-precipitation for actinide analysis in 2016 
 
Figure 2.16 shows the predominant actinide separation step.  This study will use the 
predominant actinide separation step used by 40% of the participating laboratories. 
 
Figure 2.16: The preferred method for chemical separation for actinide analysis in 2016 
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Even though the Procorad indicated that ICP-MS is a viable method to analyse low 
levels of plutonium, the market is still dominated by radio-analytical methods as 
illustrated by figure 2.17. 
 
Figure 2.17: The preferred technique for actinide analysis in 2016 
 
It is not clear which type of ICP-MS was employed, but it is expected that very few, 
if any, were Q-ICP-MS.  
 
2.6 Brief Chapter review 
The radiological hazards of plutonium, principles of analysis and the components of 
the analytical instrument (Agilent 7700) were discussed in detail. The main factors 
that affect the LOD have been investigated, and the analysis of sub-trace plutonium in 
urine using a standard Q-ICP-MS is possible when treating a large volume of urine. 
However, instrument modification or specialized instrumentation is still preferred 
over standard ICP-MS instruments and this is supported by the 2016 Procorad report 
where only 3% of at least 65 laboratories are using ICP-MS internationally. This 
study aims to determine whether a standard Q-ICP-MS can measure on par with α-
spectrometry, and in the process to fill the knowledge gap where no studies have been 
performed on a standard Q-ICP-MS using low volume sample in order to assess the 
potential of modern technology. 
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CHAPTER THREE–Research Methodology 
 
3.1 Theoretical Framework 
The research was conducted from a technological point of view. It was based on the 
premise that due to technological improvements, it is possible for a standard, modern 
Q-ICP-MS to report LOD’s/LOQ’s similar to or better than those achieved by 
previous publications on Q-ICP-MS when modified or specialist equipment was 
required to match α-spectrometry.  
 
3.2 Research Methodology 
Quantitative research was employed with an experimental design approach which is 
explained in section 3.3. This was the most suitable method because the study took 
place in a laboratory environment and quantitative data was generated. 
 
3.3 Design of experiment (DoE) 
Because this is a feasibility study, a simplified approach to the classical OVAT (one 
variable at a time) DoE will be used. The OVAT is where one factor is studied to 
determine optimal parameters, whilst other factors are kept constant (Antony, 2003)  
The experimental design approach involved the deliberate change of certain variables 
while keeping other variables constant and then assessing the outcome to determine 
the significance of each variable with respect to the outcome (Wrexhem, 2012). The 
same reference states that if a laboratory exercises strict control, then the experiment 
has objectivity and increased repeatability. It is also easy for another laboratory to 
repeat the experiment and verify the findings.   
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The disadvantages are that not all factors can be controlled or accounted for 
(Wrexhem, 2012). An example for this experiment would be that not every person 
has the same concentration of Ca2+ or PO43- in their urine. Thus precipitation kinetics 
will differ from person to person. Another disadvantage from the same reference is 
that some of the experiments might require an artificial situation which deviates from 
reality. This could lead to analyte behaving differently than it would under normal 
circumstances. An example of this would be where a blank urine sample is spiked 
with Pu, or more precisely inorganic PuNO3. The difference is that when Pu is passed 
through the body naturally, the largest fraction of urinary Pu is found in the citrate 
form (Popplewell et al., 1975). Organic plutonium citrate is a larger molecule than 
inorganic plutonium nitrate which could also affect sample stability and/or co-
precipitation.  
The DoE can be subdivided into the following experiments, in which a variable is 
evaluated that will determine the success or failure of the feasibility study. In 
chronological order: 
3.3.1 Instrument optimisation 
 Overall instrument sensitivity: The instrument was tuned in two ways. First a 
General Tune to establish a general sensitivity. Then again in High Mass Tune 
to give preference to heavier atomic masses. The higher the sensitivity, the 
lower the concentration that can be detected. 
 Integration times: Different integration times was assessed to determine how 
the precision increases over the working range. Higher precision produces 
lower LOD's/LOQ's. 
3.3.2 Sample preparation optimisation 
 Sample pre-analysis treatment: A blank urine sample underwent various pre-
analysis treatments ranging from direct analysis to co-precipitation, wet-
ashing and column separation. This determined to what extent the urine 
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matrix interferes with plutonium measurement and what the minimum sample 
preparation required was. 
 Elution optimisation: Using references as a guide, column separation was 
investigated followed by elution studies. This section was split into two parts 
namely uranium elution (washing) and plutonium elution (stripping) from a 
TEVA column.  
 
3.3.3 Evaluation of the established method 
 The LOD and LOQ that established the lowest concentrations that can be 
reported with acceptable accuracy and precision 
 Accuracy: Replicate analyses which determined intra-assay accuracy across 
the working range 
 Precision: Replicate analyses which determined intra-assay precision across 
the working range 
 Method verification: Analysis of international proficiency scheme samples 
that contain 239Pu. The result from the Q-ICP-MS was statistically compared 
to the consensus concentration from all the participating laboratories 
internationally. 
 
Should the method prove to be feasible, then a two factorial or even full factorial 
design as described by Ebrahimi-Najafabadi et al. (2014) and Anthony (2003) would 
be recommended for future studies. 
 
3.4 Materials and Reagents 
EMSURE® nitric acid (65%w/w), EMSURE® hydrofluoric acid (40%w/w), 
EMSURE® hydrogen peroxide (30% w/w) were purchased from Merck, Germany. 
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18.2 MΩ cm-1 ultra-pure deionised water was obtained from a Millipore Direct-Q 
(Merck, Germany) water purification system. 15 and 50 mL polypropylene tubes 
were obtained from LASEC (Greiner Bio-One, Germany). High purity Nalgene 
bottles were purchased from AEC Amersham, SA. An aqueous stock solution of 
239PuNO3 (7.14 GBq g-1) for calibration and 242PuNO3 (26.8 GBq g-1) for internal 
standard, were obtained from AEC Amersham, Johannesburg. Calcium nitrate (98%), 
potassium nitrite (95%) and ammonia (30% w/w) were purchased from Merck, 
Midrand. Ferrous sulphate heptahydrate (99.5%), di-hydrogen ammonium phosphate 
(99.0%) and aluminium nitrate nonahydrate were purchased from Merck, Midrand. 
Columns with 2 mL TEVA (100-150 µm particle size) were obtained from Eichrom 
Technologies, USA. 
 
3.4.1 Preparation of co-precipitation reagents 
Solutions of Ca(NO3)2 and (NH4)H2PO4 were prepared by dissolving 0.5 g of each 
salt separately in 5 mL ultra-pure water. Fresh solutions were prepared for every 
experiment. 
 
3.4.2 Preparation of valence-adjustment reagents 
The Fe(II)SO4 reducing solution was prepared by weighing 0.22 g of 
Fe(II)SO4.7H2O(s) and dissolving it in 1 mL ultrapure water. The KNO2 oxidizing 
solution was prepared by weighing 0.27 g KNO2(s) and dissolving it in 1 mL 
ultrapure water. Fresh solutions were prepared for every experiment.  
 
3.4.3 Preparation of solutions for column separation. 
The column load solution was prepared by dissolving 93.75g of Al(NO3)3.9H2O(s) in 
125 mL water, adding 34.7 mL of HNO3 and diluting to 250 mL with ultra-pure 
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water. The column rinse solution was prepared by pipetting 3.5 mL of HNO3 into 100 
mL of water and then diluting it to 250 mL with ultra-pure water. The column strip 
solution was prepared by pipetting 1.8 mL of HNO3 and 2.2 mL HF to 100 mL of 
water followed by dilution to 250 mL with ultra-pure water. The column storage 
solution was prepared by pipetting 1.8 mL of HNO3 into 100 mL of water and then 
diluting it to 250 mL with ultra-pure water. 
 
3.4.4 Preparation of calibration standards 
Intermediate standards were prepared by diluting the 239Pu to a concentration of        
10 ng L-1, and the 242Pu to a concentration of 20 ng L-1 using 1% HNO3. The 
calibration standards were prepared by mass to increase the accuracy, for example an 
empty tube was tared and the required aliquot of 239Pu pipetted before being weighed. 
The standards were then diluted with 1% HNO3 and a fixed volume of 242Pu was 
added to each tube before being weighed again. The concentration for each 
calibration standard was calculated by the following equation: 
 ܲݑ௦௧ௗ =  ܲݑ௜௡௧௘௥௠௘ௗ௜௔௧௘ ∗  ቀ ௠ೌ೗೔೜ೠ೚೟௠೟೚೟ೌ೗ ೡ೚೗.ቁ    (3.1) 
Where Puintermediate = Concentration of the intermediate standard in pg L-1. 
maliquot = Mass of the aliquot in grams 
mTotal Vol. = Mass of the total volume in grams 
 
An example of the calculation spreadsheet is attached as appendix L.  
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3.4.5 Sample Preparation (Final Procedure) 
3.4.5.1 Co-precipitation 
A 50 mL aliquot was measured into a 50 mL Falcon tube. 50 µL of tracer was added 
to each sample followed by 1 mL of CaNO3 and 1 mL of (NH4)2HPO4. The sample 
was mixed thoroughly and 5 mL of 30% NH3 added. The samples were left to stand 
for at least 2 hours before being centrifuged at 5000 rpm for 5 minutes. The 
supernatant liquid was decanted, 50 mL water added to each tube and shaken to mix 
thoroughly before being placed back into the centrifuge for 5 minutes. The sample 
was removed and the supernatant liquid discarded leaving only the precipitate. 
 
3.4.5.2 Wet-ashing 
The precipitate was dissolved in 2 mL HNO3 and transferred to a 50 mL glass beaker. 
The tube was rinsed with another 2 mL HNO3 aliquot which was transferred to the 
corresponding beaker. 1 mL of H2O2 was added to each beaker which was then placed 
on a hotplate. The samples were evaporated to dryness, preventing baking. Volumes 
of 1 mL of HNO3 and 1 mL H2O2 was added to each beaker and evaporated again. 
This step was repeated twice for the precipitate to be pure white. Samples were 
removed from the hotplate and allowed to cool to room temperature. 
 
3.4.5.3 TEVA Column separation 
The white precipitate was dissolved in 3 mL of the column load solution. 200 µL of 
the Fe(II)SO4 reducing solution was added to each sample and left for 15 minutes. 
200 µL of the KNO2 oxidizing solution was added to each sample and left for another 
15 minutes. 3 mL of 2 M HNO3 was passed through the column followed by the 
sample. The sample beakers were rinsed with 3 mL 2 M HNO3 and also passed 
through the column. The columns were then rinsed with 20 mL of 0.2 M HNO3 and 
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all the solutions collected up to this point discarded. The plutonium was stripped with 
5 mL 0.1 M HNO3:0.2 M HF solution and the eluate collected for analysis by Q-ICP-
MS. 
 
3.5 Brief Chapter review 
The quantitative research method with an experimental approach was employed, 
using the OVAT system to systematically evaluate and optimise the analytical 
method. The preparation of the reagents and calibration standards was relatively 
straight forward but because of the very low concentrations of analyte, the calibration 
standards have to be prepared by mass. The sample preparation required more effort 
to remove as much as possible urine matrix which affected the plasma conditions and 
by extend, affected the analysis. 
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CHAPTER FOUR – Results and Discussion 
4.1 Instrument Optimisation 
4.1.1 Sensitivity 
In order to increase the sensitivity and lower the background signal, a manual tune of 
instrument parameters had to be performed using a tune solution which contained 1 
µg L-1 7Li, 89Y and 205Tl, representing light-, medium- and heavy elements. The 
instrument was auto-tuned with preference to the heavy masses, monitored by the 
205Tlsignal. During auto tuning, the instrument gradually varies parameter after 
parameter and determines which settings allow for the highest sensitivity for the 
heavy masses. Auto tune is limited only to the lens- and cell parameters, meaning that 
the sample depth and nebulizer pump settings have to be changed manually. For 
comparison, a general tune report was generated (Appendix A). When the ideal 
settings were established, to ensure that precision and peak definition were not 
compromised (even if sensitivity increased), a second tune in standard mode was run 
and is attached (Appendix B). The two modes are compared in table 4.1. 
 
Table 4.1: Difference between the standard-, and high mass tune mode 
Parameter Standard tune Custom    tune Sample Depth (cm) 8 6 Nebulizer Pump (RPM) 0.1 0.2 Extract 1(V) 0 -4.4 Extract 2(V) -200 -200 Omega Bias(V) -80 -65 Cell Entrance(V) -30 -40 Cell Exit(V) -30 -40 Deflect(V) 9.4 14 Omega Lens(V) 9 13 Plate Bias(V) -40 -60 OctP Bias(V) -8.0 -8.0 OctP RF(V) 180 200 Energy Discrimination(V) 4.5 4.5 
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The RF Power, Carrier gas flow rate and Spray chamber temperature were kept 
constant at 1550 W, 1.1 L min-1 and 2 °C respectively. Table 4.2 summarises the 
performance differences between the two methods 
 
Table 4.2: Performance difference between standard and custom tune 
Parameter Standard tune Custom      tune Improvement factor 
Heavy mass Sensitivity (CPS/ppb) 5805 25629 4.41 
% RSD 3.13 2.29 1.37 
Background (CPS) 46.7 6.00 7.78 
 
 
The custom tune for heavy masses resulted in a slight increase in precision, but 
significantly increased the sensitivity and reduced background relative to the standard 
tune. The LOD will be reduced by approximately the same factor as for the increase 
in sensitivity. 
 
4.1.2 Precision 
Increasing the integration times does not increase the sensitivity but does increase the 
precision due to counting statistics. Three different integration times, 10, 20 and 30 
seconds were used and the calibration statistics obtained indicated the optimal dwell 
time. Integration times exceeding 30 seconds were not evaluated due to sample 
volume restrictions. Data is summarised in Tables 4.3 to 4.5. 
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Table 4.3: Instrument response for calibration standards at 10 seconds integration time 
Pu Standards pg L-1 Pu CPS Pu %RSD Lu-IS CPS 
0 9.79 15.1 279806 
1 10.8 12.3 281022 
5 10.6 10.7 282175 
10 12.9 9.01 282616 
50 23.9 6.40 281388 
100 41.8 5.83 280964 
500 170 1.80 283546 
 
Table 4.4: Instrument response for calibration standards at 20 seconds integration time 
Pu Standards pg L-1 Pu CPS Pu-RSD Lu-IS CPS 
0 9.83 10.1 285896 
1 9.19 8.03 286514 
5 11.2 8.75 285888 
10 12.2 6.19 286788 
50 27.1 4.26 287521 
100 41.0 3.53 283216 
500 174 1.4 286323 
 
Table 4.5: Instrument response for calibration standards at 30 seconds integration time 
Pu Standards pg L-1 Pu CPS Pu-RSD Lu-IS CPS 
0 9.58 5.53 277971 
1 9.95 7.55 278365 
5 10.7 6.61 276744 
10 11.9 4.42 276879 
50 25.6 3.14 278181 
100 41.2 2.77 270944 
500 170 1.02 276643 
 
Calibration curves were constructed by plotting the ratio of the sample CPS and the 
internal standard against the concentration of plutonium standard. The calibration 
curves for Table 4.3 to 4.5 produced Figure 4.1to 4.3. 
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Figure 4.1: Calibration curve for 10s integration time 
 
Figure 4.2: Calibration curve for 20s integration time 
  
 
 
 
 
 
 
 
Figure 4.3: Calibration curve for 30s integration time 
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When visually inspecting the calibration curves, there seemed to be little difference. 
But increasing integration times improve the counting statistics, and by extension, the 
precision. When plotting the % RSD as a function of concentration, the following 
figure was obtained: 
 
 
Figure 4.4: %RSD's for calibration standards for different integration times 
 
The increase in integration time from 10s to 30s significantly increased the overall 
precision especially at the lower concentrations (<100 pg L-1). There was a 
diminishing increase in precision from 20s to 30s compared to the increase from 10s 
to 20s. Regression statistics were performed on the 3 calibration sets and attached as 
appendix D, E and F. From the calibration statistics, the following data was obtained: 
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Table 4.6: Regression parameters for different integration times 
Integration Times Regression error(Sy/x) 
Uncertainty in intercept(Sa) Slope(b) 
Regression LOD* 
10 3.25E-06 1.41E-06 1.14E-06 4.08 
20 2.67E-06 1.16E-06 1.15E-06 3.33 
30 1.46E-06 6.34E-07 1.17E-06 1.79 * Where the regression LOD approximation is defined as LOD = 3.3Sa/b according to de Beer, 2011 
 
From Table 4.6 and Figure 4.4, it is evident that higher integration times lead to 
higher overall precision especially at lower concentrations. Because the precision 
increases, regression statistics also gradually increase, lowering the LOD 
approximation from 4.08 pg L-1 to 1.79 pg L-1.  
 
4.2 Sample Preparation Optimisation 
4.2.1 Minimum sample preparation 
Urine samples were obtained from individuals whom could not have been exposed to 
Pu containing matrices. These samples were mixed and served as a sample blank. The 
blank sample was prepared in four different ways and then analysed (starting with the 
quickest and easiest and ending with the slowest and more difficult process). The 
purpose for the experiment was to determine whether modern technology is more 
robust to changes in the sample matrix, and to determine what the minimum sample 
preparation is in order to obtain reliable results. Results are presented in Table 4.7: 
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Table 4.7: Pu concentration and IS CPS for a blank urine sample prepared by different preparations 
Sample preparation Pu(pg L-1) Lu-IS CPS 
Undiluted 1038 56826 
10X -Diluted 331 162274 Co-precipitate-1(No wet ash, No column separation) 10.1 252849 
Co-precipitate-2(Wet ash, Column separation) < 1.00 261589  
 
As the intensity of sample preparation increased, lower concentrations of Pu could be 
reported. The undiluted and diluted urine samples had the same interferences, but the 
diluted samples were a lesser load on the plasma. Signal suppression was observed, 
which was in agreement with what Hang et al., (2004), Pappas et al., (2004) and 
Zoriy et al., (2005) reported. Evans and Giglio (1993) described that organic matter 
can reduce the temperature of the plasma because of the energy required to dissociate 
molecular species like C2. Changes in the plasma temperature affect ionisation 
efficiency. Wyse et al. (1994) reported that with a direct injection nebulizer, urine can 
be analysed directly. This is however not possible because the interaction between the 
plasma and the heavy urine matrix cannot be changed. What can be changed is what 
goes into the plasma, lessening the sample load for a clean mass spectrum and robust 
plasma. This is supported by results for the co-precipitate 1 and 2. The sample that 
was not wet-ashed still contained some organic matter compared to the sample that 
was wet-ashed. Co-precipitate-1 showed slight signal suppression as well as a slight 
increase in the CPS on the m/z =239. The slight signal suppression did not increase 
the Pu-measurement after correction with internal standard. This indicates that the 
non-spectroscopic interference should be negligible, and the interference is due to a 
spectroscopic interference.  This agreed with what Pappas et al. (2004) stated. They 
observed that organic content can cause a low interference at m/z 239. This 
experiment has confirmed that full sample purification (preparation) has to be 
performed in order to analyse plutonium accurately in a urine matrix. 
38  
4.2.2 Elution optimisation 
The ideal column separation would completely remove the uranium (to remove 
238UH+ interference) and then selectively elute the plutonium in the smallest possible 
volume. A solution spiked with uranium was treated and passed through a column 
packed with TEVA resin to determine the elution profile. Data is summarised in 
Table 4.8 and illustrated in Figure 4.5. 
 
Table 4.8: Uranium rinsed from TEVA resin with 2 M HNO3 
Cumulative volume (mL) 238U(CPS) 
5 8376 
10 8007 
15 7768 
20 1411 
25 1077 
30 667 
35 475 
40 271  
 
 
Figure 4.5: Elution of uranium from TEVA-resin 
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20 mL of 2 M HNO3 was sufficient to reduce the uranium signal to below 5000 CPS 
where the 238UH+ interference was negligible.  
For plutonium elution, 0.5 mL of a 10 ng L-1 Pu solution was loaded onto the column 
and the column washed with 3 mL fractions of 0.1 M HNO3:0.2 M HF. The fractions 
were analysed separately and the results presented in table 4.9 and figure 4.6. 
 
Table 4.9: HF assisted removal of plutonium from TEVA-resin  
Cumulative volume (mL) 239Pu (CPS) 
3 239 
6 12.0 
9 10.5 
12 11.2 
 
 
 
Figure 4.6: HF assisted elution of plutonium from TEVA resin 
 
The rapid elution of plutonium from the column was possible as fluoride (from the 
HF acid) is efficient in forming stable complexes with the actinides, in this case 
plutonium. Because the plutonium is in a stable complex, it cannot re-enter the 
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stationary-phase. An initial sample of 50 mL will be processed and eluted with 5 mL 
0.1 M HNO3:0.2 M HF, yielding a concentration factor of 10. Sample LOD’s can 
then be reported ca 10x lower. 
 
4.2.3 Additional Tests 
4.2.3.1 Baking 
Wyse and Fisher (1994) mentioned that during sample wet-ashing, sample baking 
should be avoided as this causes plutonium species to become refractory. They gave 
no indication of how and to what extent the results are affected. Three urine samples 
spiked with 10 pg L-1 of Pu were taken through the whole process. One sample was 
removed from the hotplate just before dryness, another slightly baked (slight yellow 
discoloration of the white precipitate), and another excessively baked (yellow to 
brown discoloration of white precipitate). Samples were analysed and the % recovery 
calculated. 
Table 4.10: Effect of baking on Pu recovery 
Sample # Description Measured Pu (pg L-1) 
1 No baking 9.65 
2 Slight baking 7.09 
3 Excessive baking 3.34  
 
By plotting the recoveries, Figure 4.7 was obtained: 
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Figure 4.7: Effect of baking on Pu-recovery 
 
It is clear that even slight baking will affect the results significantly. For the highest 
possible recovery, even slight baking should be avoided. 
 
4.2.3.2 Interferences 
The half-lives of 239Np and 239U is 2.36 days and 23.5 minutes respectively. Isobaric 
interference from these elements were considered negligible because of their 
extremely short half-lives. It can be assumed that almost all of the 239Np and 239U will 
decay to 239Pu. 
238U presents the biggest problem because if 239Pu is present in the urine, it is highly 
probable that 238U will also be present at significantly higher concentrations which 
could cause polyatomic interference. Because uranium has similar chemical and 
physical properties will also co-precipitate and elute along with the plutonium. 
Although the method has been shown to effectively reduce the 238U to a concentration 
whereby interferences are negligibly small, it is still necessary to monitor the uranium 
signal and determine the extent of the interference to accommodate any unforeseen 
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circumstances. The combined effect of 238UH+ formation and UH-tailing was 
determined by analysing uranium standard solutions and measuring the resultant 
pseudo plutonium concentration.  The results are presented in Table 4.11. 
 
Table 4.11: Extent of uranium induced interferences. 
U Spike (ng L-1) Measured Pu (pg L-1) 
10 0 100 6.12 1000 86.3  
 
Figure 4.8 below show the linear relationship between the Uranium concentration and 
the measured pseudo plutonium concentration. And for 238U below 10 ng L-1, 
uranium induced interferences have no observable effect at m/z = 239. The 10 ng L-1 
uranium solution gave an instrument response of 5000 CPS at m/z = 239.  
 
 
Figure 4.8: Linear relationship between the uranium concentration and the increased 
plutonium measurement 
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For uranium concentrations above 10 ng L-1, inter-elemental correction will have to 
be done. The trend line equation can be used: 
PuTrue = PuMeasured - PuAmplified       (4.1) 
Where: PuAmplified = [0.087*UConc]-1.730    (4.2) 
 
4.2.3.3 Sample stability 
All analyses performed on fresh urine samples yielded tracer (242Pu) recoveries in the 
region of 70-80%. Analysis on older acidified urine samples which had a known 
concentration of 239Pu, repeatedly yielded tracer recoveries of 20-30%. This could 
possibly be due to the co-precipitation step being affected by the stabilizing agents 
and pH of the urine samples. Fresh and unpreserved urine produced a less dense, soft 
solid during co-precipitation, while the older acidified urine samples produced a 
compact solid. Initial analysis of the older acidified urine samples also gave under-
recoveries for 239Pu even when correction by tracer element was done. Pappas et al. 
(2004) reported that "analytical results depend on the time of shaking and vigour 
before removal of an aliquot" for an older sample. Re-analysis of an aliquot from a 
vigorously shaken sample produced satisfactory results. 
 
4.3 Final Method Evaluation 
4.3.1 LOD 
Normally the LOD would be expressed as 3.3*standard deviation of at least 10 blanks 
but for this study however, the theoretical LOD was calculated from a practically 
established LOQ. This results in higher confidence when reporting LOD and LOQ 
results. Theoretically: 
LOD = 3.3*Sa/b        (4.3) 
LOQ = 10*Sa/b.        (4.4) 
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Where Sa is the standards uncertainty (or standard error on excel) for the intercept, 
and b is the slope from regression statistics. By making Sa/b the subject of the 
formulas and substituting the equations, we get the following: 
 
LOD = (3.3/10) * LOQ 
         = 0.33*0.5  Note: refer to 4.3.2 for determination of LOQ 
        =0.16 pg L-1 
        ≈ 0.2 pg L-1. 
 
The sample LOD of 0.2 pg L-1 agrees with the LOD approximation made in Table 4.6 
which was from a regression curve. LOD approximation was established as            
1.79 pg L-1. Because the sample is concentrated by a factor 10, LOD approximation = 
1.79/10 = 0.18≈ 0.2 pg L-1. 
 
4.3.2 LOQ 
For every concentration, a 200 mL urine sample was spiked with a calculated 
concentration of 239Pu and divided into four 50 mL aliquots before being purified and 
analysed. For the LOQ, the lowest concentration that conforms to analysis 
specification will be the LOQ which can be reported with acceptable accuracy and 
precision. The specification was set at 50% bias for accuracy and <30% RSD using 
requirements from NECSA Safety, Health, Environment and Quality (SHEQ) 
Department as a guide. 
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Table 4.12: Accuracy and precision for various spiked concentrations (n=4) 
239Pu Spike (pg L-1) 
239Pu measured (pg L-1) % RSD % Bias 
0.10 0.00 N/A ND 
0.25 0.40 23.7 60 
0.50 0.54 11.3 8  
From the results in table 4.12, the concentration that meets both the precision and 
accuracy requirements is 0.5 pg L-1. 
 
4.3.3 Accuracy and Precision 
Urine samples collected from healthy individuals that could not have been exposed to 
Pu-containing matrixes was collected, mixed and split into two 200 mL aliquots. The 
aliquots were then spiked with 0.5- and 15 pg L-1 239Pu, respectively. Each sample 
was divided into four 50 mL aliquots, purified and analysed separately so as to 
produce signals in the low and high region of the working range. Note that the          
% accuracy is expressed in terms of the recovery of the initial concentration 239Pu 
added to the samples. This should not be confused with the method efficiency (Refer 
to appendix G). Data for the spiked samples is summarised in table 4.13. 
 
Table 4.13: Accuracy and precision for Pu in urine on both sides of working range (n=4) 
239Pu Spike (pg L-1) 
239Pu measured (pg L-1) % RSD % Accuracy 
0.5 0.54 11.3 108 
15 15 4.43 100  
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4.3.4 Method verification 
Three samples were obtained that formed part of an international Procorad 
Proficiency testing scheme. According to the ISO 13528 standard, an analytical 
method is acceptable if 2 of the 3 following tests fall within specification. The 3 tests 
are as calculated as follows: 
 
 Bias : 100 − [ቀ௑ఓቁ ∗ 100]      (4.5) 
Where X = Calculated Pu concentration 
µ = Consensus/True value 
 
 Z-Score : ቀ|௑ିఓ|௦ௗ ቁ ∗ 100      (4.6) 
Where X = Calculated Pu concentration 
            µ = Consensus value 
sd = Standard deviation of the consensus value 
 
 En (Normalized error) : ቌ |௑ିఓ|ට௎ಽೌ್మ ା௎ೃ೐೑మ ቍ    (4.7) 
Where X = Calculated Pu concentration 
 µ = Consensus value 
௅ܷ௔௕ଶ  = Expanded uncertainty (95%) of the measured value 
ܷோ௘௙ଶ  = Expanded uncertainty (95%) of the consensus value 
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That the method is currently not validated and thus has no expanded uncertainty 
values thus normalized error can therefore not be calculated. The consensus results 
are expressed a mBq per sample and this method reports pg L-1. The conversion was 
calculated as follows: 
ܲݑ(௠஻௤ ௣௘௥ ௦௔௠௣௟௘) = (ܲݑ(ூ஼௉) ∗ ܲݑ(ௌ௣ ஺௖௧)) ∗  ௌ௔௠௣௟௘ ௏௢௟(೘ಽ)ଵ଴଴଴ ௠௅   (4.8) 
 Where: Pu(ICP) = Measured 239Pu concentration from Q-ICP-MS in pg L-1 
              Pu(Sp Act) = Specific activity for 239Pu = 2.296 mBq pg-1 
              Sample Vol(mL) = Total volume of original sample. 
 
All procorad samples submitted has a total volume of 500 mL. The results obtained 
for the analysis of these samples are presented in table 4.14. 
 
Table 4.14: Results for the Procorad proficiency samples 
Procorad sample Measured result  (pg L-1) Converted result (mBq per sample) Consensus result (mBq per sample) A 2.4 2.8 2.2 B 4.3 4.9 4.4 C 0.2 0.3 0.0  
For Consensus results, refer to appendix I-K. Since sample C is a blank sample, it 
would not be considered when performing the evaluation calculation.  
 
Table 4.15: Summary of the evaluation criteria for the proficiency samples 
Tests Criteria Sample A Sample B Status Bias (%) -25 to 50% 16.7 11.4 Pass Z-score -3 to 3 2.1 1.5 Pass  
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The results obtained by the Q-ICP-MS method fell within specification for at least 2 
out of the 3 tests and thus the method was regarded as having been verified 
sufficiently to be acceptable internationally. 
 
4.3.5 Creatinine normalisation 
A single 50 mL sample is viewed as a spot sample and the measured Pu concentration 
does not give sufficient information since it is influenced by the total volume of urine 
excreted in a 24-hour cycle. By normalising with creatinine, it was not necessary to 
collect a full 24-hour urine sample. By assuming that the average male (weighing 70 
kg) and female (weighing 60 kg) excretes roughly 1575 and 1050 mg creatinine per 
day, respectively (Horowitz, 2014), and the average volume excreted is 1600 mL and 
1200 mL respectively (ICRP, 2003), the samples can be normalised to Pu 
concentration per mass creatinine. The average man, with an average creatinine 
excretion through an average urine volume, will excrete 0.049 g creatinine per 50 
mL, and a female 0.044 g per 50 mL.   
Creatinine normalised values were obtained from the following calculations. 
Equation 4.9 shows the conversion of the concentration of Pu in 1 L to concentration 
per gram of creatinine. Equation 4.10 shows the conversion from concentration per 
gram of creatinine to radioactive counts (in mBq) per gram of creatinine. 
 
ܲݑ(௣௚ ௣௘௥ ௚) = ௉௨(಺಴ು)∗ 
ఱబ ೘ಽభబబబ ೘ಽ ஼       (4.9) 
 Where: Pu(ICP) = Measured 239Pu concentration from Q-ICP-MS in pg L-1. 
                           C= Grams of creatinine per 50 mL urine (different for males and females). 
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ܲݑ(௠஻௤ ௣௘௥ ௚) = ቂ൫௉௨(಺಴ು)∗௉௨(ೄ೛ ಲ೎೟)൯∗ 
ఱబ ೘ಽభబబబ ೘ಽ ቃ஼      (4.10) 
Where: Pu(ICP) = Measured 239Pu concentration from Q-ICP-MS in pg L-1 
             Pu(Sp Act) = Specific activity for 239Pu = 2.296 mBq pg-1 
               C= Grams of creatinine per 50 mL urine (different for males and females). 
 
The creatinine normalised reporting limits and ranges are summarised in Table 4.16 
and 4.17 for males and females, respectively. 
 
Table 4.16: Creatinine normalised measurement parameters for males 
Parameter Pu(pg g-1) Pu(mBq g-1) 
LOD 0.2 0.5 
LOQ 0.5 1.2 
Working range 0.5-102 1.2-234  
 
Table 4.17: Creatinine normalised measurement parameters for females 
Parameter Pu(pg g-1) Pu(mBq g-1) 
LOD 0.2 0.5 
LOQ 0.6 1.3 
Working range 0.6-114 1.3-260 
 
 
4.4 Brief Chapter Review 
The instrumentation was successfully tuned for increased sensitivity and precision at 
large m/z ratios. The minimum sample preparation was a full purification step 
including co-precipitation, wet-ashing and solid-phase separation leading to a sample 
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concentration factor of 10. The method LOD and LOQ were established as 0.2 and 
0.5 pg L-1 respectively. Method accuracy, i.t.o. bias has been established as 8% for 
0.5 pg L-1 and 0% for 15 pg L-1 and method precision was 11.3% and 4.43% RSD for 
the same concentrations. The method was verified using samples from an 
international proficiency study. 
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CHAPTER FIVE–CONCLUSION AND RECOMMENDATIONS 
 
5.1 Conclusion 
The study has shown that it is possible to analyse for 239Pu concentrations in urine 
samples at concentrations as low as 0.2 pg L-1 using an unmodified Q-ICP-MS, thus 
leading to the rejection of the null hypothesis (Ho) that had been proposed. The 
sensitivity of the instrument was increased by a factor of 4. Sample purification 
(using the adsorbent column) was shown to be important in reducing interferences 
and improving the LOD by a factor of 10. It was also possible to reduce uranium to a 
level where 238UH+ interferences were considered negligible. Acceptable bias (of 
50%) and precision (<30% in terms of % RSD’s) were obtained over the analytical 
working range.  Furthermore, the increase in sensitivity due to optimisation made it 
possible to reduce the sample volume required from > 500 mL to just 50 mL. The 
method was verified using samples from an international proficiency scheme spiked 
with Pu and the results were satisfactory. The turnaround time from sample 
preparation to analysis was reduced significantly compared to α-spectrometry. The 
method also meets all the requirements of the NECSA SHEQ department. However, 
the method robustness can be improved as was noted by the loss of analyte when 
shaking, baking was carried out on the samples. The method also requires fresh 
solutions to be prepared as Fe (in the reagents) tends to oxidise quickly upon 
extended exposure to the atmosphere. The presence of 239U and 239Np was not 
ascertained in the study, but it may be important to determine them in future studies.  
The creatinine normalisation was also done with an average creatinine per sex. But 
the values can vary drastically depending on water intake (Horowitz, 2014). For more 
accurate analysis or future applications, it might be necessary to quantify the 
creatinine. Some of the recommendations that can be followed to further improve the 
method and increase its feasibility are mentioned below.  
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5.2 Recommendations 
5.2.1 Reducing the total sample preparation time 
Additional tests that were not part of the scope of the feasibility study include 
reducing the standing time during the co-precipitation step in 15 minute intervals to 
determine at which point the yield reaches maximum as well as reducing the standing 
time during the valence adjustment steps in 2 minute intervals to determine optimum 
yield. These tests can form part of a multi-variate experimental design for the method 
validation process. 
 
5.2.2 Further reduction of LOD’s 
In order to report even lower LOD's, method or instrument adjustments can be made 
to increase either the concentration factor or the abundance sensitivity (CPS/ug L-1). 
From the least expensive to the most expensive they are: 
 Increase the sample volume. The higher the sample volume processed, the higher 
the concentration factor. By using 50 mL sample, the concentration factor is 10. 
By using 1000 mL, effectively 20 times lower concentrations can be reported with 
the same accuracy.  
 
 Install a different sample introduction system. By installing an ultrasonic 
nebulizer, the transport efficiency is increased to 15% compared to 1-2% for 
pneumatic nebulizers as reported by Wyse and Fisher (1994) This will allow 
analysing of concentrations 7 to 15 times lower with the same precision. 
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5.2.3 Analysis of multiple actinides 
To expand this method to include multiple actinides, the elution volumes per actinide 
should be 5 mL. By implementing a 30s integration time, the Q-ICP-MS uses 4.5 mL 
per actinide including a tracer (242Pu) and uranium monitoring.   
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Appendix A-Standard Tune (Quartz introduction system) 
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Appendix B-Heavy mass specific Tune (Quartz Introduction system) 
 
 
 
60  
Appendix C-Heavy mass specific Tune (PFA Introduction) 
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Appendix D- Regression statistics for 10s integration times 
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Appendix E- Regression statistics for 20s integration times 
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Appendix F- Regression statistics for 30s integration times   
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Appendix G- Erroneous data: Pu determination with Uranium removal, without 
tracer. 
The following results were obtained when spiked urine samples were prepared in 
replicate and analysed. The procedure was: Co-precipitation, wet-ashing, solid phase 
extraction. After column load, 20 mL 2 M HNO3 was passed through the column to 
strip any matrix elements as well as uranium. Plutonium was then stripped with 5 mL 
0.1 M HNO3+ 0.2 M HF.  
Spiked sample replicates read as follows: 
 
Table G1: The measured values from spiked urine samples 
Pu-spike (pg L-1) 
1 15 
Urine spike 0.77 ± 0.12 10.28 ± 0.7 
 
By modifying the data, the following table was obtained: 
 
Table G2: Analysis parameters for urine matrix across the working range. 
Pu-spike (pg L-1) 
Parameter 1 15 
Method efficiency (%) 77.3 68.6 
Precision (%) 11.6 4.63 
 
The under-recoveries have led to the transition from Lu as internal standard to Pu242 
as an internal standard. Because the 242Pu undergoes the same procedure as 239Pu, it 
corrects more efficiently for 239Pu loss from co-precipitation up to solid-phase 
extraction   
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Appendix H- Erroneous data: Pu determination without complete Uranium 
removal, with tracer. 
The following results were obtained when spiked urine samples were prepared in 
replicate, 242Pu internal standard added and analysed. The procedure was: Co-
precipitation, wet-ashing, solid phase extraction. After column load, 10 mL 0.5M 
HNO3 was passed through the column to strip any matrix elements. Plutonium was 
then stripped with 5 mL 0.1 M HNO3+ 0.2 M HF.  
 
Table H1: The measured values from spiked urine samples 
Pu-spike (pg L-1) 
1 15 
Urine spike 1.42 ± 0.13 15.3 ± 0.9 
 
By modifying the data, the following table was obtained: 
 
Table H2: Analysis parameters for urine matrix across the working range. 
Pu-spike (pg L-1) 
Parameter 1 15 
Bias (%) 42 2 
Precision (%) 9.15 6.03 
 
From the data there is a clear spike for the 239Pu. The interference was more 
pronounced on the low spike. The suspect was determined to be uranium from either 
contaminated glassware or incomplete column separation.  Samples generated 238U 
CPS >15 000CPS and it has been established that uranium CPS should be kept < 
5000CPS. Thus there was clear evidence of uranium induced interferences. As 
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preventative action, all glassware was left overnight in 10% HNO3 and rinsed three 
times with ultra-pure water. Column rinse was additionally changed from 10 mL to 
20 mL to ensure that if there was higher than expected uranium, most would be 
removed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67  
Appendix I- 2016 Procorad Sample A 239Pu results 
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Appendix J- 2016 Procorad Sample B 239Pu results 
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Appendix K -2016 Procorad Sample C 239Pu results 
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Appendix L –Example of calibration standard calculation form. 
Analysis Date : 2016/07/25  
Pu Stock  Conc : 1 µg/L  
Aliquot(g) Total mass(g)  Calc Conc  Pu Intermediate 0,1023 10,2882  9,94 ng/L  
5 pg/L Conc 0,0054 9,7486  5,5 pg/L  10 pg/L Conc 0,0102 9,9385  10,2 pg/L  20 pg/L Conc 0,0197 10,2026  19,2 pg/L  50 pg/L Conc 0,0491 9,8727  49,5 pg/L  100 pg/L Conc 0,0998 9,9619  99,6 pg/L  
 
